Edition:
India

G1 Therapeutics Inc (GTHX.OQ)

GTHX.OQ on NASDAQ Stock Exchange Global Select Market

58.80USD
20 Sep 2018
Change (% chg)

$-1.20 (-2.00%)
Prev Close
$60.00
Open
$58.98
Day's High
$60.42
Day's Low
$57.62
Volume
214,652
Avg. Vol
120,155
52-wk High
$69.23
52-wk Low
$18.45

Chart for

About

G1 Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in developing small-molecule therapies for the treatment of cancer. Its two clinical-stage candidates are trilaciclib (G1T28) and G1T38, which are potent, selective inhibitors of the validated kinase targets CDK4/6. Trilaciclib and G1T38... (more)

Overall

Beta: --
Market Cap(Mil.): $731.75
Shares Outstanding(Mil.): 28.29
Dividend: --
Yield (%): --

Financials

BRIEF-G1 Therapeutics Reports Qtrly Loss Per Share Of $0.70

* G1 THERAPEUTICS PROVIDES FIRST QUARTER 2018 CORPORATE AND FINANCIAL UPDATE

04 May 2018

Earnings vs. Estimates